Hochschulschrift
The anti-tumourigenic action of the progesterone receptor antagonist Lonaprisan (ZK230211) in breast cancer
- Weitere Titel
-
Die anti-tumorigene Wirkung des Progesteron Rezeptor Antagonist Lonaprisan (ZK230211) in Brustkrebs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Freie Universität Berlin, Diss., 2011
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Freie Universität Berlin
- (wann)
-
2011
- Urheber
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000025253-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Busia, Laura
- Freie Universität Berlin
Entstanden
- 2011
Ähnliche Objekte (12)
Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET
Activity of the GHRH antagonist MIA-602 and its underlying action mechanisms in endometriosis and breast cancer
![Medikamentöse Prophylaxe gastrointestinaler Komplikationen nach Nierentransplantation mit dem H2-Receptor-Antagonist [H-Receptor-Antagonist] Cimetidin](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Medikamentöse Prophylaxe gastrointestinaler Komplikationen nach Nierentransplantation mit dem H2-Receptor-Antagonist [H-Receptor-Antagonist] Cimetidin
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Gastrin-releasing peptide receptor antagonist [68Ga]RM2 PET/CT for staging of pre-treated, metastasized breast cancer
The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
Effect of Ions and Sequence Variants on the Antagonist Binding Properties of the Histamine H1 Receptor
Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET
Activity of the GHRH antagonist MIA-602 and its underlying action mechanisms in endometriosis and breast cancer
Medikamentöse Prophylaxe gastrointestinaler Komplikationen nach Nierentransplantation mit dem H2-Receptor-Antagonist [H-Receptor-Antagonist] Cimetidin
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Gastrin-releasing peptide receptor antagonist [68Ga]RM2 PET/CT for staging of pre-treated, metastasized breast cancer
The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
Effect of Ions and Sequence Variants on the Antagonist Binding Properties of the Histamine H1 Receptor
Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925
The role of Interleukin-1-Receptor-Antagonist in bladder cancer cell migration and invasion
Gastrin-releasing peptide receptor imaging in breast cancer using the receptor antagonist 68Ga-RM2 and PET
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET
Activity of the GHRH antagonist MIA-602 and its underlying action mechanisms in endometriosis and breast cancer
Medikamentöse Prophylaxe gastrointestinaler Komplikationen nach Nierentransplantation mit dem H2-Receptor-Antagonist [H-Receptor-Antagonist] Cimetidin
EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine
Gastrin-releasing peptide receptor antagonist [68Ga]RM2 PET/CT for staging of pre-treated, metastasized breast cancer
The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo
The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
Effect of Ions and Sequence Variants on the Antagonist Binding Properties of the Histamine H1 Receptor
Synthesis, characterization, and in vitro evaluation of the selective P2Y2 receptor antagonist AR-C118925